The average one-year price target for Tactile Systems Technology (NasdaqGM:TCMD) has been revised to $30.34 / share. This is ...

For the full year 2025, CFO Birkemeyer reported, "we now expect total revenue in the range of $310 million to $315 million, representing growth of approximately 6% to 8% year-over-year." The guidance ...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even companies that have no revenue, no profit, and a record of falling short, can manage ...

Shares of Tactile Systems Technology (NASDAQ: TCMD) fell as much as 18.5% early Tuesday, then settled to close down 3.2% after the medical technology company announced mixed quarterly results and ...

CEO Sheri Dodd reported strong Q4 financial performance, with total revenue of $85.6 million, marking a 10.2% year-over-year increase. Lymphedema business line sales rose 11% year-over-year and 18.1% ...

Fintel reports that on January 5, 2026, Piper Sandler upgraded their outlook for Tactile Systems Technology (NasdaqGM:TCMD) ...

Tactile Systems Technology (TCMD) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces ...

Minneapolis-based Tactile Systems, an at-home compression therapy device company, will go public on Thursday with an offer of $10 per share, significantly lower than the offering ranges submitted to ...

Tactile Medical's fourth-quarter 2023 revenue grew 5% year over year to $77.7 million, translating to adjusted (non-GAAP) net income of $8.9 million, or $0.37 per share. Analysts, on average, were ...